Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular diagnosis of inherited platelet disorder via a targeted whole-exome virtual gene panel: a 5-year institutional experience.

Research and practice in thrombosis and haemostasis·2026

Same author

Refining current risk stratification guidelines for pregnant women with Fontan circulation: lessons from PROFAT registry.

European journal of preventive cardiology·2025

Same author

Recurrent thrombosis and major bleeding in children treated for VTE.

Blood advances·2025

Same author

Prothrombin prevents fatal T cell-dependent anemia during chronic virus infection of mice.

JCI insight·2025

Same author

Hemostatic derangements associated with cardiopulmonary bypass predict outcomes in pediatric patients undergoing corrective heart surgery.

Journal of thrombosis and haemostasis : JTH·2024

Same author

Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesity.

Journal of thrombosis and haemostasis : JTH·2024

Search research articles

Related Experiment Video

Updated: May 21, 2026

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Hemostatic factors, innate immunity and malignancy.

Jay L Degen¹, Joseph S Palumbo

¹Cancer and Blood Diseases Institute, Cincinnati Children's Research Foundation, Cincinnati, OH 45229, USA.

Thrombosis Research

|June 12, 2012

Summary

The hemostatic system, involving blood clotting factors, significantly impacts cancer growth and spread. Targeting these factors offers a promising strategy to inhibit tumor development and metastasis.

Area of Science:

Oncology
Hematology
Immunology

Background:

Genetics studies highlight the role of tumor-associated tissue factor and thrombin regulators in metastasis.
Emerging evidence links hemostatic factors to innate immune function and early cancer development.
The platelet/fibrin(ogen) axis and fibrinogen's role in leukocyte activation are crucial in early tumor formation.

Purpose of the Study:

To explore the multifaceted role of the hemostatic system in cancer pathogenesis.
To investigate how hemostatic factors influence tumor biology and metastasis.
To assess the potential of targeting hemostatic factors as a cancer therapy.

Main Methods:

Review of genetics-based studies on hemostatic factors and cancer.
Analysis of reports on platelet/fibrin(ogen) interactions in metastasis.

More Related Videos

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Related Experiment Videos

Last Updated: May 21, 2026

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Examination of studies on fibrinogen's role in inflammation-driven colon cancer and leukocyte activation.

Investigation of platelet-derived factors in promoting epithelial-mesenchymal transition.

Main Results:

Hemostatic factors are critical in metastasis, influencing tumor cell biology and innate immunity.
The platelet/fibrin(ogen) axis limits natural killer cell activity against micrometastases.
Fibrinogen supports early tumor development by promoting leukocyte activation.
Platelet factors can induce a more invasive phenotype in tumor cells, suggesting evolving malignant properties.

Conclusions:

The hemostatic system plays a significant, multifaceted role in cancer pathogenesis.
Interactions between hemostatic factors and tumor cells can program malignant phenotypes.
Targeting specific hemostatic factors presents a powerful therapeutic strategy to impede tumor development and metastasis.